Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

AMS earnings analysis

Filed August 13, 2026 · Our reading of the company's report

The latest report

AMS reported Q2 revenue of $8.43 million, beating the $7.56 million consensus estimate, but diluted EPS of $(0.07) missed the $(0.02) estimate. The filing continues to disclose ineffective controls as of June 30, 2026,…

Read full summary

AMS reported Q2 revenue of $8.43 million, beating the $7.56 million consensus estimate, but diluted EPS of $(0.07) missed the $(0.02) estimate. The filing continues to disclose ineffective controls as of June 30, 2026, following a material weakness related to staffing and experience, while the CFO resigned in July 2026. Covenant noncompliance and obligations that matured on April 9, 2026 remain important liquidity risks despite the Fifth Third maturity extension to June 30, 2027. No quantitative forward guidance was provided.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

45% Gross margin Operating margin May 2023 Aug 2025

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish May 2023 Aug 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$-0.07

What stood out

  • Revenue beat, but EPS missed

    Reported Q2 revenue was $8.43 million, above the $7.56 million consensus estimate, although diluted EPS was $(0.07) versus the $(0.02) estimate.

  • Debt maturity extended to 2027

    The Third Amendment dated July 22, 2026 extended the Fifth Third credit agreement maturity to June 30, 2027, and neither Fifth Third nor DFC had accelerated the obligations as of the filing.

  • Revenue-cycle remediation underway

    The company brought Rhode Island revenue-cycle management in-house and hired an experienced revenue-cycle director, 2 staff members, and an accounting manager to address billing and reporting controls.

What to watch

  • Material weakness remains unresolved

    Disclosure controls were concluded to be ineffective as of June 30, 2026 because of a material weakness involving insufficient personnel and resources with relevant experience. Management stated the remediation may take time and provided no assurance that it will have the intended effects.

  • CFO transition adds execution risk

    CFO Scott Frech resigned in July 2026 for personal reasons and was replaced on an interim basis by Chief Accounting Officer Alexis Tirrito, increasing execution risk while the control remediation remains in process.

  • Covenant and liquidity pressure

    ASHS and certain subsidiaries were not in compliance with covenants as of June 30, 2026, and outstanding obligations were not satisfied when the Fifth Third agreement matured on April 9, 2026. Although the maturity was later extended to June 30, 2027, the filing indicates ongoing lender and liquidity risk.

Management's outlook

No quantitative forward revenue or EPS guidance was provided in the 10-Q; outlook was deferred to the earnings release or call.

Earlier filings 4

10-Q · May 14, 2026

American Shared Hospital Services reported total revenue of $7,084,000 in Q1 2026, reflecting a 15.9% increase from $6,112,000 in Q1 2025. However, the company posted a diluted EPS of -$0.09, missing the consensus…

10-K · March 31, 2026

American Shared Hospital Services (ASHS) positions itself as a provider of turn-key stereotactic radiosurgery and advanced radiation therapy through two reportable segments (medical equipment leasing and direct patient…

10-Q · August 13, 2025

Q2 2025 revenue was essentially flat year-over-year at $7,071,000 (up $15,000 vs. Q2 2024) while EPS was a loss of $0.04 per share. Leasing revenue declined to $3,571,000 (down $328,000 YoY) but direct patient services…

10-Q · May 15, 2025

American Shared Hospital Services reported first-quarter 2025 revenue of $6,112,000, up $896,000 (17.2%) versus Q1 2024, driven by direct patient services. However, the company recorded a net loss attributable to the…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.